SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-138911
Filing Date
2023-05-09
Accepted
2023-05-09 07:36:03
Documents
15
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d450885d8k.htm   iXBRL 8-K 28628
2 EX-99.1 d450885dex991.htm EX-99.1 92011
7 GRAPHIC g450885g09f34.jpg GRAPHIC 27678
  Complete submission text file 0001193125-23-138911.txt   334872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xomao-20230509.xsd EX-101.SCH 3909
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xomao-20230509_def.xml EX-101.DEF 14165
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xomao-20230509_lab.xml EX-101.LAB 23506
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xomao-20230509_pre.xml EX-101.PRE 15199
9 EXTRACTED XBRL INSTANCE DOCUMENT d450885d8k_htm.xml XML 6650
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 23900003
SIC: 2834 Pharmaceutical Preparations